Vorozole

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

Key facts

Vorozole is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including CYP19A1.

• Molecular targets: CYP19A1 (1 listed in DrugCentral).
• ATC code: L02BG05 (Aromatase inhibitors).
• Molecular formula: C16H13ClN6; molecular weight 324.77 g/mol.

Mechanism & targets

Molecular targets (1)

Target	Gene	Action	Activity
Aromatase	CYP19A1	inhibitor	IC50 8.86

ATC classification

ATC code	Therapeutic hierarchy
L02BG05	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS › ENDOCRINE THERAPY › HORMONE ANTAGONISTS AND RELATED AGENTS › Aromatase inhibitors

Chemical structure

• Molecular formula: C₁₆H₁₃ClN₆
• Molecular weight: 324.77 g/mol
• CAS number: —
• InChIKey: XLMPPFTZALNBFS-INIZCTEOSA-N
• PubChem CID: 6918191

CN1N=NC2=C1C=C(C=C2)[C@@H](N1C=NC=N1)C1=CC=C(Cl)C=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Vorozole work?

Its molecular targets in DrugCentral include CYP19A1 (inhibitor).

What is the chemical formula of Vorozole?

Vorozole has the molecular formula C16H13ClN6 and a molecular weight of 324.77 g/mol.

Sources

• DrugCentral drug card 3651 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL224060 — compound record and bioactivity
• PubChem CID 6918191 — chemical identifiers
• DrugBank DB13767 — drug record
• FDA UNII 1E2S9YXV2A — substance identity
• UniProt P11511 (CYP19A1) — target protein

How this page is built: methodology · editorial policy & corrections.